Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Top Takeaways from HIMSS 2019

HIMSS 2019 wraps up in Orlando, Florida today after five days of healthcare industry learning and collaboration. If you missed anything from the show, MarketScale has you covered. Make sure to read up on the key themes, events and speeches that HIMSS Senior Director of Strategic Communications Karen Groppe made note of if you have…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

HIMSS 2019 wraps up in Orlando, Florida today after five days of healthcare industry learning and collaboration. If you missed anything from the show, MarketScale has you covered.

Make sure to read up on the key themes, events and speeches that HIMSS Senior Director of Strategic Communications Karen Groppe made note of if you have not already.

Also see everything you may have missed from the beginning of the show HERE:

Innovation is why people come to events like HIMSS 2019, and there were plenty of learning opportunities at this year’s show. Augmented reality may be one of the biggest breakthroughs coming to the medical field soon. Artificial intelligence will also provide insight into the human body.

#AR is being used today in real-world applications, perhaps none more exciting than surgery! #HIMSS19 @ATTBusiness #ATTInfluencer @daniel_kraft #magicleap @magicleap @magicleapdevs #medtech #healthcare @Jennifer_Espo pic.twitter.com/XslTyE9vu6
— Evan Kirstel (@EvanKirstel) February 12, 2019

#AI Can See 👀 Inside Living Human Cells!#HealthTech #DigitalHealth #AI #Cancer #ArtificialInteligence #healthcare via @automeme #HIMSS2019 pic.twitter.com/IkT1aAdAEQ
— #Healthcare 😷 🌐 (@HealthcareLdr) February 12, 2019

On Friday morning, Dr. Don Rucker, the National Coordinator for Health Information Technology in the Department of Health and Human Services of the United States Government gave his thoughts on the industry.

.@donrucker: This is a very international process. We’re actively discussing healthcare across the globe and leveraging standards developed in other countries like #FHIR. #HealthIT #HIMSS19 pic.twitter.com/VSnUVgWPyJ
— ONC (@ONC_HealthIT) February 15, 2019

Different perspectives coming together is a goal of every industry trade show and there was no shortage of it at HIMSS 2019.

.@SiemensHealth's Joerg Aumueller shares how #artificialintelligence has gone from buzzword to clinical routine @Siemens @siemens_press #healthIT #HIMSS19 @JohnNosta @IrmaRaste #ai pic.twitter.com/GoK3O0L8dv
— Evan Kirstel (@EvanKirstel) February 15, 2019

The two goals of the proposed rule are straight forward:
🔹Open up the data in electronic medical records to empower the patients.
🔹Stop information blocking. #NPRM #CuresNPRM #HIMSS19 #HealthIT #EHR pic.twitter.com/3XMeLNeiOq
— MarieGabrielleLaguna (@docprogrammer) February 15, 2019

https://twitter.com/FortinetHealth/status/1096412328990572546

Chuck Brooks from @ExtremeNetworks sharing lessons learned from recent cyber attacks #HIMSS19 #IHPavilion pic.twitter.com/Wt78lnR41W
— Lauren Farah (@Laur_Farah) February 13, 2019

The smartphone is a tool that has to be part of the #healthit conversation, which is part of the drive behind what @ONC_HealthIT is doing, Don Rucker says during #HIMSS19 keynote w/ Hal @HalWolfIII pic.twitter.com/kvMqM0omMz
— Matthew (@mpweinstock) February 15, 2019

It is possible to walk miles on a given day at a trade show the size of HIMMS 2019, but some attendees still mustered up the energy to hit the bike for a good cause.

Final day! Help make wishes come true! Bike-o-meter is at 200 miles. Help Optum donate to @MakeAWish Central and Northern Florida for critically ill children. Come cycle @Optum booth 5979 #HIMSS19. pic.twitter.com/FJncxGqBB8
— Optum (@Optum) February 14, 2019

For others, they found interactive experiences that were less taxing on the body.

We’re off to the races with @lexmark at #HIMSS2019 ! pic.twitter.com/38XdqOuRd4
— Allison Fantony (Correia) (@AllisonFantony) February 14, 2019

Stay tuned for more coverage of the HIMSS 2019 conference all week and interact with us on social media!

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512